EnteroBiotix Funding: $34M Raised, Series B (2024)
EnteroBiotix is based in Aberdeen, Scotland. It has raised $34M in total funding. Latest round: Series B.
EnteroBiotix funding overview
EnteroBiotix is based in Aberdeen, Scotland. EnteroBiotix has raised $34M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in April 2024. The round record for EnteroBiotix runs through 2024; nothing later has been disclosed. Investors on record include Thairm Bio, Kineticos Life Sciences, Scottish National Investment Bank, Scottish Enterprise. 4 distinct backers are named across the disclosed rounds.
EnteroBiotix at a glance
Total raised
$34M
Latest round
Series B
Latest round date
April 2024
Headquarters
Aberdeen, Scotland
Notable investors
Thairm Bio, Kineticos Life Sciences, Scottish National Investment Bank, Scottish Enterprise
Frequently asked about EnteroBiotix funding
How much has EnteroBiotix raised?
EnteroBiotix has raised $34M in total disclosed funding across the rounds on record.
Who has invested in EnteroBiotix?
Thairm Bio, Kineticos Life Sciences, Scottish National Investment Bank, Scottish Enterprise are named among the investors backing EnteroBiotix.
What was the latest EnteroBiotix funding round?
The most recent disclosed round is a Series B, announced in April 2024.
Where is EnteroBiotix based?
EnteroBiotix is based in Aberdeen, Scotland.
When did EnteroBiotix last raise?
The last disclosed EnteroBiotix round closed in April 2024 at Series B.
EnteroBiotix totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Aberdeen below to benchmark round size and investor mix.
